Williams Robert JR Sells Shares of AVAH
Williams Robert JR sold 1 million shares of AVAH, valued at $8 million, on June 24.
Key Points
- Williams Robert JR sold 1 million shares of AVAH at $8 each on June 24, 2026, for a total value of $8 million.
- Shares of AVAH traded near $8.48 on Friday, with institutional activity showing mixed changes in holdings.
- Analysts recently set price targets for AVAH, with Barclays maintaining a buy rating and a $9 target.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 24, 2026, Williams Robert JR sold 1 million shares of AVAH at $8 per share, amounting to a total transaction value of $8 million. This sale was not executed under a pre-arranged trading plan.
Other Institutional Activity in AVAH
Several institutional investors adjusted their positions in AVAH recently. Nut Tree Capital Management, LP increased its holdings by 550,000 shares, bringing its total to 12,922,649 shares valued at approximately $83.2 million, marking a 4.4% increase. BlackRock, Inc. reduced its stake by 656,532 shares, now holding 5,500,912 shares worth around $35.4 million, a decrease of 10.7%. Summit Partners L P also reduced its holdings by 2.1 million shares, ending with 5,451,422 shares valued at $35.1 million, a 27.8% decrease. Meanwhile, Vanguard Capital Management LLC opened a new position with 3,974,819 shares valued at about $25.6 million.
Aveanna Healthcare Holdings Inc. Stock Down 36.3%
Shares of AVAH traded near $8.48 on Friday. The company's recent trading activity has shown varied interest from institutional investors, reflecting a dynamic market environment.
$AVAH stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at Aveanna Healthcare Holdings Inc.
On June 24, 2026, J.H. Whitney Equity Partners VII, LLC sold 919,389 shares of AVAH at $8 each. Paul Vigano also sold 1 million shares at the same price. Both transactions were not part of pre-planned trading. Earlier in June, on the 3rd, Paul Vigano and Williams Robert JR each sold 7 million shares at $6.24 per share.
Analysts Set New Price Targets
Analysts have been active in setting new price targets for AVAH. On May 18, 2026, Barclays maintained its buy rating with a price target of $9. Stephens & Co. upgraded the stock to a buy with an $11 target on May 15. RBC Capital maintained a hold rating with a $10 target on the same day. Truist Securities also maintained a hold rating with a target of $8 on April 13.
Bottom Line
Williams Robert JR's recent sale of AVAH shares highlights ongoing insider activity within the company. Investors often track such transactions to gauge insider sentiment. While the 13F filings provide insight into institutional holdings, they are backward-looking and may not reflect current positions. Analyst ratings and price targets also offer valuable perspectives on the stock's potential trajectory.
Get Aveanna Healthcare Holdings Inc. alerts
New 13F filings, insider trades, and analyst moves on $AVAH, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.